Tag: ALK fusion

Lorlatinib Prolongs Progression-Free Survival in ALK-Positive Lung Squamous Carcinoma

November 7, 2026

A multicenter retrospective study of 54 patients found that lorlatinib significantly extended progression-free survival compared to earlier-generation inhibitors in ALK ...

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Human Mobility Data Across Ten Cities Shows Pervasive Location-Specific Bias

Research report: Degradation mechanisms of Si/Nb/Zr/NbZr-modified TiCN coatings under 200 keV He+ ion irradiation: surface morphology and defect structure

Research report: Diagnostic utility of salivary CRP, MPV, NLR, and PLR in neonatal sepsis: a prospective case-control study

Subscribe to Blog via Email

Join 86 other subscribers

No Result

View All Result

Tag: ALK fusion

Lorlatinib Prolongs Progression-Free Survival in ALK-Positive Lung Squamous Carcinoma

POPULAR NEWS

Review Traces How NAT10 and RNA Acetylation Drive Diverse Human Diseases

Machine Learning Predicts Diabetes Risk in NAFLD Patients

Probiotic Fermentation Enhances Flavor and Stability in Pasteurized Kiwifruit Juice

Scoping Review Finds Plant-Driven Greenhouse Control Rare

About

Follow us

Recent News

Human Mobility Data Across Ten Cities Shows Pervasive Location-Specific Bias

Research report: Degradation mechanisms of Si/Nb/Zr/NbZr-modified TiCN coatings under 200 keV He+ ion irradiation: surface morphology and defect structure

Research report: Diagnostic utility of salivary CRP, MPV, NLR, and PLR in neonatal sepsis: a prospective case-control study

Subscribe to Blog via Email

Welcome Back!

Retrieve your password